NCT00192140 - Trial to Assess the Shedding,Immunogenicity, and Safety of FluMist Administered to Healthy Individuals 5-49 Years of Age | Biotech Hunter

Enrollment

345

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

October 31, 2004

Study Completion Date

January 31, 2005

Conditions

Influenza

Interventions

BIOLOGICAL

FluMist

A single intranasal dose of FluMist will be administered to approx. 300 subjects.

Trial Locations (11)

Primary Physician's Research Inc., Pittsburgh

University of Maryland, School of Medicine, Baltimore

University of Virginia, Elson Student Health Center, Charlottesville

Marshall University Medical Center, Huntington

SFBC International, Inc, Miami

Vanderbilt University Medical Center North, Nashville

Kentucky Pediatric / Adult Research, Inc, Bardstown

Pediatric Clinical Trials International, Columbus

Children's Memorial Hospital, Chicago

Center for Vaccine Development, St Louis

Creighton University Medical Center, Omaha